Mechanisms of antioxidant and pro-oxidant effects of α-lipoic acid in the diabetic and nondiabetic kidney

Kidney International

Volumn 67, Issue 4, 2005, Pages 1371-1380

  Bhatti, Faizah ^b   Mankhey, Richard W ^b   Asico, Laureano ^b   Quinn, Mark T ^b   Welch, William J ^b   Maric, Christine ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Diabetes; Kidney; Oxidative stress; lipoic acid

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALBUMIN; ANTIOXIDANT; CREATININE; GLUCOSE; PROTEIN P22; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE EXACERBATION; ENZYME ACTIVITY; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; MALE; METABOLISM; MORPHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; STREPTOZOCIN DIABETES; URINARY EXCRETION;

EID: 16244413938     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00214.x     Document Type: Article

References (50)

1. KOO JR, NI Z, OVIESI F, VAZIRI ND: Antioxidant therapy potentiates antihypertensive action of insulin in diabetic rats. Clin Exp Hypertens 24:333-344, 2002
2. KITADA M, KOYA D, SUGIMOTO T, et al: Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes 52:2603-2614, 2003
3. LI JM, SHAH AM: ROS generation by nonphagocytic NADPH oxidase: Potential relevance in diabetic nephropathy. J Am Soc Nephrol 14:S221-S226, 2003
4. FORBES JM, THALLAS V, THOMAS MC, et al: The breakdown of pre-existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J 17:1762-1764, 2003
5. EVANS JL, GOLDFINE ID, MADDUX BA, GRODSKY GM: Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev 23:599-622, 2002
6. DINCER Y, TELCI A, KAYALI R, et al: Effect of alpha-lipoic acid on lipid peroxidation and anti-oxidant enzyme activities in diabetic rats. Clin Exp Pharmacol Physiol 29:281-284, 2002
7. ISHII N, PATEL KP, LANE PH, et al: Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol 12:1630-1639, 2001
8. 1 receptor and NADPH oxidase. Hypertension 42:206-212, 2003
9. KASHIWAGI M, SHINOZAKI M, HIRAKATA H, et al: Locally activated renin-angiotensin system associated with TGF-beta1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats. J Am Soc Nephrol 11:616-624, 2000
10. ONOZATO ML, TOJO A, GOTO A, et al: Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 61:186-194, 2002
11. VEELKEN R, HILGERS KF, HARTNER A, et al: Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol 11:71-79, 2000
12. KOMERS R, LINDSLEY JN, OYAMA TT, et al: Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes. Am J Physiol Renal Physiol 279:F573-F583, 2000
13. JE HD, SHIN CY, PARK HS, et al: The comparison of vitamin C and vitamin E on the protein oxidation of diabetic rats. J Auton Pharmacol 21:231-236, 2001
14. OBROSOVA IG, FATHALLAH L, STEVENS MJ: Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy. Exp Neurol 172:211-219, 2001
15. JACHEC W, TOMASIK A, TARNAWSKI R, CHWALINSKA E: Evidence of oxidative stress in the renal cortex of diabetic rats: Favourable effect of vitamin E. Scand J Clin Lab Invest 62:81-88, 2002
16. KOYA D, HAYASHI K, KITADA M, et al: Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 14:S250-S253, 2003
17. CRAVEN PA, DERUBERTIS FR, KAGAN VE et al: Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes. J Am Soc Nephrol 8:1405-1414, 1997
18. PACKER L, WITT EH, TRITSCHLER HJ: alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19:227-250, 1995
19. CARREAU JP: Biosynthesis of lipoic acid via unsaturated fatty acids. Methods Enzymol 62:152-158, 1979
20. MOINI H, PACKER L, SARIS N: Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 182:84-90, 2002
21. BAST A, HAENEN G: Lipoic acid: a multifunctional antioxidant. Biofactors 17:207-213, 2003
22. MELHEM MF, CRAVEN PA, LIACHENKO J, DE RUBERTIS FR: Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Am Soc Nephrol 13:108-116, 2002
23. MARITIM AC, SANDERS RA, WATKINS JB: Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 14:288-294, 2003
24. OBROSOVA IG, FATHALLAH L, LIU E, NOUROOZ-ZADEH J: Early oxidative stress in the diabetic kidney: Effect of DL-alpha-lipoic acid. Free Radic Biol Med 34:186-195, 2003
25. NAGAMATSU M, NICKANDER K, SCHMELZER J, et al: Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18:1160-1167, 1995
26. OBROSOVA IG, FATHALLAH L, GREENE DA: Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: Effect of DL-alpha-lipoic acid. Eur J Pharmacol 398:139-146, 2000
27. SAITO T, SUMITHRAN E, GLASGOW EF, ATKINS RC: The enhancement of aminonucleoside nephrosis by the co-administration of protamine. Kidney Int 32:691-699, 1987
28. TANEDA S, PIPPIN JW, SAGE EH, et al: Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol 14:968-980, 2003
29. KITIYAKARA C, CHABRASHVILI T, CHEN Y, et al: Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 14:2775-2782, 2003
30. SCHNACKENBERG CG, WILCOX CS: Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin f2alpha. Hypertension 33:424-428, 1999
31. BURRITT JB, QUINN MT, JUTILA MA, et al: Topological mapping of neutrophil cytochrome b epitopes with phage-display libraries. J Biol Chem 270:16974-16980, 1995
32. DE LEO FR, ULMAN KV, DAVIS AR, et al: Assembly of the human neutrophil NADPH oxidase involves binding of p67phox and flavocytochrome b to a common functional domain in p47phox. J Biol Chem 271:17013-17020, 1996
33. CHABRASHVILI T, TOJO A, ONOZATO ML, et al: Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39:269-274, 2002
34. MELHEM MF, CRAVEN PA, DERUBERTIS FR: Effects of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Nephrol 12:124-133, 2001
35. MELHEM MF, CRAVEN PA, LIACHENKO J, DERUBERTIS FR: Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Am Soc Nephrol 13:108-116, 2002
36. CATHERWOOD MA, POWELL LA, ANDERSON P, et al: Glucose-induced oxidative stress in mesangial cells. Kidney Int 61:599-608, 2002
37. MERVAALA E, FINCKENBERG P, LAPATTO R, et al: Lipoic acid supplementation prevents angiotensin II-induced renal injury. Kidney Int 64:501-508, 2003
38. HAMADA Y, ARAKI N, KOH N, et al: Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway. Biochem Biophys Res Commun 228:539-543, 1996
39. DERUBERTIS F, CRAVEN P: Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43:1-8, 1994
40. HA H, KIM K: Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. Diabetes Res Clin Pract 45:147-151, 1999
41. FUMO P, KUNCIO G, ZIYADEH F: PKC and high glucose stimulate collagen alpha 1 (IV) transcriptional activity in a reporter mesangial cell line. Am J Physiol 267:F632-F638, 1994
42. YILMAZ O, OZKAN Y, YILDIRIM M, et al: Effects of alpha lipoic acid, ascorbic acid-6-palmitate, and fish oil on the glutathione, malonaldehyde, and fatty acids levels in erythrocytes of streptozotocin induced diabetic male rats. J Cell Biochem 86:530-539, 2002
43. ETOH T, INOGUCHI T, KAKIMOTO M, et al: Increased expression of NAD(P)H oxidase subunits, NOX4 and p22nhox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabetologia 46:1428-1437, 2003
44. ZHAN CD, SINDHU RK, VAZIRI ND: Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: Reversal by lifelong antioxidant supplementation. Kidney Int 65:219-227, 2004
45. SCOTT B, ARUOMA O, EVANS P, et al: Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radic Res 20:119-133, 1994
46. MOINI H, PACKER L, SARIS NE: Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 182:84-90, 2002
47. RELJANOVIC M, REICHEL G, RETT K, et al: Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha lipoic acid in diabetic neuropathy. Free Radic Res 31:171-179, 1999
48. BORCEA V, NOUROOZ-ZADEH J, WOLFF S, et al: alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic Biol Med 26:1495-1500, 1999
49. RUHNAU KJ, MEISSNER HP, FINN JR, et al: Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med 16:1040-1043, 1999
50. MARANGON K, DEVARAJ S, TIROSH O, et al: Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress. Free Radic Biol Med 27:1114-1121, 1999